The Effect of QVA149 on Patient Reported Dyspnea in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

NCT01490125 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

247

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: QVA149
DRUG: Tiotropium
DRUG: Placebo to QVA149
DRUG: Placebo to tiotropium
DRUG: Salbutamol/albuterol

Sponsor

Novartis Pharmaceuticals